Versor Investments’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,897
Closed -$613K 651
2025
Q3
$613K Sell
1,897
-3,500
-65% -$1.09M 0.11% 260
2025
Q2
$2.1M Buy
5,397
+2,898
+116% +$1.17M 0.37% 30
2025
Q1
$1.09M Buy
+2,499
New +$1M 0.18% 177
2024
Q4
Sell
-875
Closed -$455K 816
2024
Q3
$455K Buy
+875
New +$467K 0.07% 447
2024
Q2
Sell
-1,801
Closed -$934K 785
2024
Q1
$934K Buy
+1,801
New +$896K 0.19% 157
2023
Q4
Sell
-487
Closed -$212K 750
2023
Q3
$212K Sell
487
-879
-64% -$399K 0.04% 578
2023
Q2
$607K Sell
1,366
-1,134
-45% -$523K 0.11% 204
2023
Q1
$1.15M Buy
+2,500
New +$1.19M 0.15% 91
2022
Q4
Sell
-3,011
Closed -$1.37M 791
2022
Q3
$1.37M Buy
3,011
+1,508
+100% +$722K 0.08% 149
2022
Q2
$725K Buy
1,503
+600
+66% +$297K 0.03% 358
2022
Q1
$444K Buy
+903
New +$413K 0.02% 362
2020
Q3
Sell
-2,489
Closed -$655K 302
2020
Q2
$655K Buy
2,489
+667
+37% +$178K 0.06% 56
2020
Q1
$414K Sell
1,822
-2,634
-59% -$718K 0.03% 133
2019
Q4
$1.35M Sell
4,456
-9,200
-67% -$2.53M 0.07% 105
2019
Q3
$3.28M Buy
13,656
+2,600
+24% +$712K 0.22% 46
2019
Q2
$3.12M Buy
11,056
+5,550
+101% +$1.52M 0.21% 69
2019
Q1
$1.58M Buy
+5,506
New +$1.59M 0.15% 68

Other funds holding ELV

Versor Investments's ELV Position: Q4 2025 in Review

Versor Investments sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,897 shares — an estimated $613K sold.

Versor Investments first reported a position in ELV in Q1 2019 and held it in 17 quarters. The position peaked at $3.28M in Q3 2019. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Versor Investments reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Versor Investments sold 1,897 Elevance Health shares in Q4 2025, an estimated $613K.
  • Versor Investments first reported a position in Elevance Health in Q1 2019 and held it in 17 quarters.
  • Versor Investments's Elevance Health position peaked at $3.28M in Q3 2019.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Versor Investments's 13F filing for Q4 2025, filed 4 Feb 2026.